Many liver diseases share a common characteristic: fibrosis, that is, the progressive accumulation of scarring in the liver ...

For many years, it was believed that when an individual develops liver scarring, it can not be reversed. Today, we know that ...

Many liver diseases share a common characteristic: fibrosis, the progressive accumulation of scarring in the liver tissue.

The FDA granted breakthrough therapy designation to efimosfermin — an investigational, once-monthly fibroblast growth factor ...

Liver fibrosis, a pathological condition in which the liver becomes stiff and scarred, commonly develops in the progression of chronic liver diseases such as chronic hepatitis and metabolic ...

Liver fibrosis is a feature of many hepatic diseases, including metabolic dysfunction-associated steatohepatitis (MASH). Various candidate drugs directly targeting mechanisms of fibrosis have shown ...

New research and updated guidelines highlight the urgent need to standardize noninvasive liver fibrosis screening as metabolic dysfunction-associated steatotic liver disease (MASLD) cases climb ...

Researchers at Spain’s National Cancer Research Centre have uncovered how bile duct cells actively protect the liver from ...

As a hepatologist, Aleksander Krag has always sought to improve the prognosis of patients with liver disease, whom, he tells The Lancet, he often thinks of as a fictional patient he calls “Henry”. His ...

BOSTON — In the staging of liver fibrosis in the post-liver transplant setting, readings from noninvasive tests commonly have major discrepancies when compared with liver biopsy results, particularly ...

Scientists have discovered that combining two existing drugs can dramatically reduce liver fat linked to a common and often silent disease. The treatment not only improved liver health in animal ...